Shruti Mehta

Summary

Affiliation: Johns Hopkins Bloomberg School of Public Health
Country: USA

Publications

  1. ncbi request reprint HIV incidence among injection drug users in Baltimore, Maryland (1988-2004)
    Shruti H Mehta
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21202, USA
    J Acquir Immune Defic Syndr 43:368-72. 2006
  2. doi request reprint Emergence of cocaine and methamphetamine injection among HIV-positive injection drug users in Northern and Western India
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States Electronic address
    Drug Alcohol Depend 135:160-5. 2014
  3. pmc Stability of liver fibrosis among HCV-infected injection drug users
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Antivir Ther 17:813-21. 2012
  4. pmc Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers
    Ryan P Westergaard
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, 600 Highland Ave, Madison, WI, USA
    J Int AIDS Soc 15:10. 2012
  5. pmc Factors associated with injection cessation, relapse and initiation in a community-based cohort of injection drug users in Chennai, India
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Addiction 107:349-58. 2012
  6. pmc Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV
    M Bradley Drummond
    Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
    BMC Pulm Med 10:27. 2010
  7. pmc The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India
    Sunil S Solomon
    YR Gaitonde Centre for AIDS Research and Education, VHS Adyar, Taramani, Chennai 600113, India
    BMC Public Health 11:39. 2011
  8. ncbi request reprint Liver enzyme values in injection drug users with chronic hepatitis C
    S H Mehta
    Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA
    Dig Liver Dis 37:674-80. 2005
  9. ncbi request reprint Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users
    S H Mehta
    Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    AIDS Care 19:637-45. 2007
  10. ncbi request reprint High HIV prevalence among a high-risk subgroup of women attending sexually transmitted infection clinics in Pune, India
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21202, USA
    J Acquir Immune Defic Syndr 41:75-80. 2006

Detail Information

Publications59

  1. ncbi request reprint HIV incidence among injection drug users in Baltimore, Maryland (1988-2004)
    Shruti H Mehta
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21202, USA
    J Acquir Immune Defic Syndr 43:368-72. 2006
    ..We examined recent trends (1999-2004) in HIV incidence among a cohort of injection drug users (IDUs) followed since 1988 in Baltimore, Maryland...
  2. doi request reprint Emergence of cocaine and methamphetamine injection among HIV-positive injection drug users in Northern and Western India
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States Electronic address
    Drug Alcohol Depend 135:160-5. 2014
    ..Little is known regarding the epidemiology of drug injection and risk behaviors among injection drug users (IDUs) across India. In particular, there is limited data on the prevalence of stimulant injection...
  3. pmc Stability of liver fibrosis among HCV-infected injection drug users
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Antivir Ther 17:813-21. 2012
    ....
  4. pmc Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers
    Ryan P Westergaard
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, 600 Highland Ave, Madison, WI, USA
    J Int AIDS Soc 15:10. 2012
    ..We sought to estimate the degree to which providers of HIV care defer initiation of ART because of injection drug use and to identify clinic and provider-level factors associated with resistance to prescribing ART to IDUs...
  5. pmc Factors associated with injection cessation, relapse and initiation in a community-based cohort of injection drug users in Chennai, India
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Addiction 107:349-58. 2012
    ..To characterize factors associated with injection cessation, relapse and initiation...
  6. pmc Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV
    M Bradley Drummond
    Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
    BMC Pulm Med 10:27. 2010
    ..We characterized the independent and joint effects of HIV and OLD on respiratory symptoms of a cohort of inner-city IDUs...
  7. pmc The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India
    Sunil S Solomon
    YR Gaitonde Centre for AIDS Research and Education, VHS Adyar, Taramani, Chennai 600113, India
    BMC Public Health 11:39. 2011
    ..1 million injection drug users (IDUs) in India; the majority are likely married. We characterize HIV, hepatitis B (HBV) and hepatitis C (HCV) prevalence and the risk environment of a sample of spouses of IDUs...
  8. ncbi request reprint Liver enzyme values in injection drug users with chronic hepatitis C
    S H Mehta
    Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA
    Dig Liver Dis 37:674-80. 2005
    ..Liver enzymes fluctuate in chronic hepatitis C virus infection. However, the range that can be attributed to the course of hepatitis C virus (versus an intercurrent cause of hepatitis) is unknown...
  9. ncbi request reprint Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users
    S H Mehta
    Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    AIDS Care 19:637-45. 2007
    ..Interventions to reduce treatment interruptions and to provide continuity of HIV care during incarceration among IDUs are needed to improve responses and subsequent survival...
  10. ncbi request reprint High HIV prevalence among a high-risk subgroup of women attending sexually transmitted infection clinics in Pune, India
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21202, USA
    J Acquir Immune Defic Syndr 41:75-80. 2006
    ..To investigate changes over a decade in prevalence and correlates of HIV among high-risk women attending sexually transmitted infection (STI) clinics in Pune, India, who deny a history of commercial sex work (CSW)...
  11. ncbi request reprint Serum albumin as a prognostic indicator for HIV disease progression
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland 21205, USA
    AIDS Res Hum Retroviruses 22:14-21. 2006
    ....
  12. pmc Limited uptake of hepatitis C treatment among injection drug users
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    J Community Health 33:126-33. 2008
    ..Low HCV treatment effectiveness was observed in this IDU population. Comprehensive integrated care strategies that incorporate education, case-management and peer support are needed to improve care and treatment of HCV-infected IDUs...
  13. ncbi request reprint A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA
    AIDS 19:S179-89. 2005
    ....
  14. pmc Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
    Clin Infect Dis 50:1664-71. 2010
    ..We characterized temporal trends in highly active antiretroviral therapy (HAART) initiation (1996-2008) among treatment-eligible persons in a community-based cohort of current and former injection drug users (IDUs) in Baltimore, Maryland...
  15. pmc Assessment of liver disease (noninvasive methods)
    Shruti H Mehta
    Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, Maryland 21231, USA
    Curr Opin HIV AIDS 6:465-71. 2011
    ..Overall, in 2010-2011, 15 studies were published, of which two were excluded because they were published in languages other than English...
  16. pmc Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Indian J Med Res 132:706-14. 2010
    ..We characterized HCV antibody prevalence, viral persistence, genotype and liver disease prevalence among IDUs in Chennai, India as the study of the association of HIV with each of these states is important and there are no data available...
  17. pmc Changes in blood-borne infection risk among injection drug users
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    J Infect Dis 203:587-94. 2011
    ..Population-level hepatitis C virus (HCV) infection incidence is a surrogate for community drug-related risk...
  18. ncbi request reprint Hepatitis C virus infection and incident type 2 diabetes
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA
    Hepatology 38:50-6. 2003
    ..05-4.40). In conclusion, pre-existing HCV infection may increase the risk for type 2 diabetes in persons with recognized diabetes risk factors. Additional larger prospective evaluations are needed to confirm these preliminary findings...
  19. ncbi request reprint Progression of liver fibrosis among injection drug users with chronic hepatitis C
    Lucy E Wilson
    Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21231 1002, USA
    Hepatology 43:788-95. 2006
    ..In this setting with low fibrosis prevalence, FibroSURE, ALT, and APRI tests predict insignificant fibrosis; however, further work is needed to find noninvasive markers of significant liver fibrosis...
  20. ncbi request reprint Same-sex behavior and high rates of HIV among men attending sexually transmitted infection clinics in Pune, India (1993-2002)
    Amita Gupta
    Division of Infectious Disease, Johns Hopkins School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA
    J Acquir Immune Defic Syndr 43:483-90. 2006
    ..To determine HIV/sexually transmitted infection (STI) prevalence, trends, and risk behaviors of men who have sex with men (MSM) and compare these with those of non-MSM attending STI clinics in Pune, India over a 10-year period...
  21. ncbi request reprint Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection
    Rajesh Kannangai
    Department of Pathology, The Johns Hopkins School of Medicine, Baltimore, MD 21231, USA
    J Clin Virol 39:101-5. 2007
    ..Given that typical chronic HBV infections often have periodic flairs in viral replication and liver damage, we hypothesized that occult HBV may also have flares in viral replication that are associated with increased liver enzymes...
  22. ncbi request reprint Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults
    Mark S Sulkowski
    Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    AIDS 21:2209-16. 2007
    ....
  23. ncbi request reprint Effect of micronutrients and iron supplementation on hemoglobin, iron status, and plasma hepatitis C and HIV RNA levels in female injection drug users: a controlled clinical trial
    Richard D Semba
    Department of Ophthalmology, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA
    J Acquir Immune Defic Syndr 45:298-303. 2007
    ..Iron deficiency is common among female injection drug users, but it is unclear whether iron supplementation can reduce anemia and improve iron status without increasing plasma hepatitis C virus (HCV) or HIV RNA levels...
  24. ncbi request reprint Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, USA
    AIDS 20:2361-9. 2006
    ..To evaluate predictors and trends of referral for hepatitis C virus (HCV) care, clinic attendance and treatment in an urban HIV clinic...
  25. ncbi request reprint Protection against persistence of hepatitis C
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA
    Lancet 359:1478-83. 2002
    ..However, HCV infection and vaccination in chimpanzees has been shown to reduce the magnitude and duration of viraemia with re-challenge. We aimed to establish whether similar immunity could be achieved in man...
  26. ncbi request reprint Hepatitis C and progression of HIV disease
    Mark S Sulkowski
    Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument St, Room 448, Baltimore, MD 21287 0003, USA
    JAMA 288:199-206. 2002
    ..Conflicting reports exist regarding the effect of hepatitis C virus (HCV) on the progression of human immunodeficiency virus (HIV) disease...
  27. ncbi request reprint The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland 21287, USA
    J Acquir Immune Defic Syndr 33:577-84. 2003
    ..DESIGN Retrospective cohort analysis of 1230 persons on their first HAART regimen who had at least 1 random glucose measurement before and during antiretroviral therapy...
  28. pmc High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern
    Sunil S Solomon
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    J Acquir Immune Defic Syndr 49:327-32. 2008
    ..To estimate the prevalence of HIV and hepatitis C virus (HCV) and hepatitis B virus (HBV) coinfections and current risk behaviors among HIV-positive and -negative injection drug users (IDUs) in Chennai, India...
  29. pmc Factors associated with the perpetration of sexual violence among wine-shop patrons in Chennai, India
    Vivian F Go
    Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
    Soc Sci Med 71:1277-84. 2010
    ..HIV interventions that facilitate formal groups that foster positive social support and address a range of HIV risk behaviors including sexually and physically abusive behaviors are recommended to reduce sexual violence...
  30. pmc The profile of injection drug users in Chennai, India: identification of risk behaviours and implications for interventions
    Sunil S Solomon
    Johns Hopkins School of Public Health, Baltimore, Maryland, USA
    Subst Use Misuse 45:354-67. 2010
    ....
  31. pmc Human immunodeficiency virus-related microbial translocation and progression of hepatitis C
    Ashwin Balagopal
    Division of Infectious Diseases, Viral Hepatitis Center, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Gastroenterology 135:226-33. 2008
    ..We hypothesized that HIV promotes liver disease by enhancing microbial translocation...
  32. doi request reprint Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland
    Mohamed G Atta
    Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Clin Infect Dis 45:1625-32. 2007
    ..It is unknown how the widespread use of highly active antiretroviral therapy (HAART) has affected survival during RRT in this vulnerable population...
  33. ncbi request reprint HIV infection is associated with an increased risk for lung cancer, independent of smoking
    Gregory D Kirk
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
    Clin Infect Dis 45:103-10. 2007
    ..Human immunodeficiency virus (HIV)-infected persons have an elevated risk for lung cancer, but whether the increase reflects solely their heavy tobacco use remains an open question...
  34. pmc Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution
    Xiao Hong Wang
    Viral Hepatitis Center, Div of Inf Dis, Department of Medicine, Johns Hopkins University School of Medicine, 1503 E Jefferson Street, Suite 114, Baltimore, MD 21231, USA, and Southwest Hospital, Chongqing, People s Republic of China
    J Virol 81:6513-22. 2007
    ..Thus, in a small but carefully matched cohort we found evidence for rapid neutral evolution of HCV in persons with rapid progression of hepatic fibrosis, suggesting higher turnover of infected cells...
  35. pmc Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users
    Lauren M Kucirka
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    J Infect Dis 202:845-52. 2010
    ..Accurate estimates of prevalence and risk factors are important to help clinicians decide who to screen...
  36. ncbi request reprint The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD 21205 0003, USA
    Hepatology 41:123-31. 2005
    ..Recognition of bridging fibrosis and cirrhosis in some but not most patients underscores the importance of identifying and treating liver disease in HIV/HCV coinfected persons...
  37. pmc Exceeding the limits of liver histology markers
    Shruti H Mehta
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 1830 E Monument St, Room 455 ID, Baltimore, MD 21287, USA
    J Hepatol 50:36-41. 2009
    ..We characterized the magnitude of the impact of error in the "gold standard" on the observed diagnostic accuracy of surrogate markers...
  38. pmc Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection
    Gregory D Kirk
    Department of Epidemiology, Schools of Public Health and Medicine, Johns Hopkins University, Baltimore, Maryland 21205, USA
    Clin Infect Dis 48:963-72. 2009
    ..We compared elastography with histologic methods among hepatitis C virus (HCV)-infected and human immunodeficiency virus (HIV)-HCV-coinfected participants in an urban, predominantly black study population...
  39. pmc Nonstructured treatment interruptions among injection drug users in Baltimore, MD
    Ravi Kavasery
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    J Acquir Immune Defic Syndr 50:360-6. 2009
    ..We characterized patterns of highly active antiretroviral therapy (HAART) use and predictors of nonstructured treatment interruptions (NTIs) among injection drug users (IDUs) in Baltimore, MD...
  40. pmc Variations in sexual risks in drug users: emerging themes in a behavioral context
    David D Celentano
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Helath, 615 North Wolfe Street Suite E 6547, Baltimore, MD 21205, USA
    Curr HIV/AIDS Rep 5:212-8. 2008
    ..Special attention is paid to minority populations, both sexual and racial/ethnic, as their marginalized role in contemporary society places special barriers to risk reduction...
  41. ncbi request reprint Correlates of unsafe syringe acquisition and disposal among injection drug users in Baltimore, Maryland
    Elizabeth T Golub
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
    Subst Use Misuse 40:1751-64. 2005
    ..These data suggest the need for a more active program involving pharmacists, an expanded syringe access program, and better efforts to enhance safe disposal...
  42. ncbi request reprint The effect of HIV infection on overdose mortality
    Cunlin Wang
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    AIDS 19:935-42. 2005
    ..To quantify the association of HIV infection with overdose mortality and explore the potential mechanisms...
  43. pmc Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users
    Dale M Netski
    Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland
    J Clin Microbiol 42:1631-6. 2004
    ..Reproducibility, low technical requirements, and high throughput should make this assay useful for clinical or research monitoring of HCV levels during active infection...
  44. ncbi request reprint Mortality risk among new onset injection drug users
    David Vlahov
    Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Addiction 99:946-54. 2004
    ..To characterize mortality experience among those who only recently started injection...
  45. ncbi request reprint End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004
    Gregory M Lucas
    Department of Medicine, Divisions of Infectious Diseases, Bloomberg School of Public Health, John Hopkins University, Baltimore, Maryland, USA
    AIDS 21:2435-43. 2007
    ..HIV-infected African-Americans are at increased risk of end-stage renal disease requiring renal replacement therapy (RRT)...
  46. pmc Determinants of alcohol consumption in HIV-uninfected injection drug users
    Petra M Sander
    Department of Epidemiology, The Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599, USA
    Drug Alcohol Depend 111:173-6. 2010
    ..This study demonstrates that in a large urban cohort of persons with a history of injection drug use, risky drug use and sexual risk behavior are associated with subsequent alcohol consumption...
  47. ncbi request reprint Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus
    Mark S Sulkowski
    Division of Infectious Diseases Johns Hopkins School of Medicine, Baltimore, Maryland 21287, USA
    AIDS 19:585-92. 2005
    ....
  48. ncbi request reprint Knowledge, attitudes, and practices of antiretroviral therapy among HIV-infected adults attending private and public clinics in India
    Suneil R Ramchandani
    Department of Internal Medicine, National Naval Medical Center, Bethesda, Maryland, USA
    AIDS Patient Care STDS 21:129-42. 2007
    ..In order to make widespread dissemination of ART effective in India, further educational and programmatic efforts are likely needed to optimize access, treatment awareness, and compliance among patients with HIV...
  49. ncbi request reprint CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection
    Dale M Netski
    Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, 21231, USA
    J Infect Dis 195:857-63. 2007
    ..These disease interactions may result in part from impairment of B cell function, which is CD4(+) T cell dependent...
  50. pmc Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users
    Jonathan E Golub
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA
    J Acquir Immune Defic Syndr 49:532-7. 2008
    ..Between 1990 and 1998, tuberculin skin tests (TST) and isoniazid preventive therapy (IPT) were provided to injection drug users participating in the AIDS Linked to the Intravenous Experiences cohort...
  51. ncbi request reprint Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections
    Mark S Sulkowski
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD21205, USA
    Hepatology 35:182-9. 2002
    ..Severe hepatotoxicity occurs throughout the course of NNRTI therapy and is more common among patients prescribed nevirapine, those coinfected with HCV or HBV, and those coadministered protease inhibitors...
  52. ncbi request reprint Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir
    Mark S Sulkowski
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    AIDS 18:2277-84. 2004
    ....
  53. ncbi request reprint Peripheral blood count abnormalities among patients with hepatitis C in the United States
    Michael B Streiff
    Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD, USA
    Hepatology 35:947-52. 2002
    ..0 x 10(9)/L or platelet counts less than 100 x 10(9)/L. Alternate causes of anemia should be considered for HCV-infected persons with low red blood cell counts...
  54. doi request reprint Perioperative mortality and long-term survival following live kidney donation
    Dorry L Segev
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    JAMA 303:959-66. 2010
    ..More than 6000 healthy US individuals every year undergo nephrectomy for the purposes of live donation; however, safety remains in question because longitudinal outcome studies have occurred at single centers with limited generalizability...
  55. ncbi request reprint Impact of diabetes on mortality among patients with community-acquired bacteremia
    Chu Lin Tsai
    Department of Emergency Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, No 7, Chung Shan South Road, Taipei 100, Taiwan
    J Infect 55:27-33. 2007
    ..To assess the impact of diabetes on 30-day mortality in patients with community-acquired bacteremia..
  56. pmc Non-fatal overdose and subsequent drug treatment among injection drug users
    Robin A Pollini
    Department of Family and Preventive Medicine, School of Medicine, University of California, San Diego, CA 92093, USA
    Drug Alcohol Depend 83:104-10. 2006
    ..Interventions that provide drug treatment information and enhance motivation for treatment in the medical setting and policies that reduce barriers to treatment entry among motivated drug users are recommended...
  57. ncbi request reprint Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index
    Thomas B Kelleher
    Liver Center, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis Street, Suite 8E, Boston, MA 02215, USA
    J Hepatol 43:78-84. 2005
    ..To examine if serum fibrosis biomarkers could accurately identify the stage of liver disease amongst hepatitis C (HCV) and HIV co-infected patients...
  58. ncbi request reprint Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India
    Bijal Shah
    Department of Emergency Medicine, Carolinas Medical Center, Charlotte, NC, USA
    Clin Infect Dis 44:1235-44. 2007
    ..Adherence to antiretroviral therapy (ART) and correlates of adherence and virologic suppression among human immunodeficiency virus (HIV)-infected persons receiving ART in private, outpatient clinics in India is unknown...
  59. ncbi request reprint Response to overdose among injection drug users
    Robin A Pollini
    Department of Family and Preventive Medicine, School of Medicine, University of California San Diego, San Diego, California, USA
    Am J Prev Med 31:261-4. 2006
    ..This study characterizes responses to overdose among injection drug users (IDUs) in Baltimore, Maryland, and identifies factors associated with medically inappropriate response...

Research Grants14

  1. INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
    Shruti Mehta; Fiscal Year: 2009
    ..The findings from this study will inform HIV prevention and structural interventions and will help to project the future health care needs for aging IDUs with a changing spectrum of morbidity. ..
  2. INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
    Shruti H Mehta; Fiscal Year: 2010
    ..The findings from this study will inform HIV prevention and structural interventions and will help to project the future health care needs for aging IDUs with a changing spectrum of morbidity. ..
  3. INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
    Shruti Mehta; Fiscal Year: 2009
    ..The findings from this study will inform HIV prevention and structural interventions and will help to project the future health care needs for aging IDUs with a changing spectrum of morbidity. ..
  4. INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
    Shruti Mehta; Fiscal Year: 2007
    ..abstract_text> ..
  5. INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
    Shruti Mehta; Fiscal Year: 2007
    ..abstract_text> ..
  6. HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
    Shruti H Mehta; Fiscal Year: 2010
    ..to inform interventions to reduce the morbidity and mortality associated with drug use, HIV and hepatitis C. ..